|
IPSA
International, Inc. – The Company
IPSA International, Inc. (IPSA) is a global provider of high-end
investigative, business intelligence and risk mitigation services
to the international corporate community. IPSA’s core services
include:
 |
Corporate investigations |
|
Competitor intelligence and counter-espionage |
|
Intellectual property protection |
|
Corporate and individual due diligence
and background investigations |
IPSA is active in several global industries, including: pharmaceuticals
and life sciences, technology, manufacturing, banking and natural
resources. Established in 1993, IPSA is a privately-held company
that is independent of any other business relationship and free
of any such conflicts. IPSA maintains its corporate headquarters
in the San Francisco Bay Area and has 13 regional offices throughout
North America, including:
- Atlanta
- Boston
- Chicago
- Dallas
- Los Angeles
- Mexico City
- Miami
- New York
- Phoenix
- Seattle
- Toronto
- Vancouver
IPSA's senior professionals all have backgrounds from all of
the major governmental and private sector disciplines, including
former Federal law enforcement (FBI, DEA), international intelligence
agencies (CIA), and investigative, forensics, accounting and financial
firms. In addition to IPSA’s professional team, IPSA maintains
a global network of intelligence and investigative resources –
personnel who are based in over 75 countries. IPSA’s assignments
are conducted all over the world and on behalf of some of the
largest companies in the world. IPSA’s core philosophy centers
on risk prevention and pre-incident planning which positions its
clients to react effectively and efficiently when and if a risk
event occurs.
Risks in the Pharmaceutical Industry
Given the international scope and dynamic nature and of the pharmaceutical
industry, its participants, whether large, publicly-traded companies
or privately-held specialty companies, face a wide range of risks.
Among the more prevalent issues faced by the pharmaceutical industry
today are:
|
Product counterfeiting |
|
Product diversion and gray market activity |
|
Product piracy |
|
Theft of trade secrets |
|
Violation of intellectual property |
|
Economic espionage |
|
Physical/plant security |
|
Eco-terrorism |
Almost every large capitalization and numerous smaller pharmaceutical
companies have been targeted by counterfeiters and diverters and
have had their products stolen, either by external parties or
through internal fraud. In addition, the theft of trade secrets
and other proprietary knowledge, methods and procedures is a constant
workplace threat. In extreme cases, a number of pharmaceutical
companies have had their facilities – domestically and abroad
– targeted by eco-terrorists such as militant animal rights
activists. The most recent high profile attack in the U.S. was
the August 2003 bombing of a Chiron Corporation facility in California.
|
Sub Menu
Services
Contact
Us
Visit Our Website
Address
|
IPSA International, Inc. |
| |
1801 SW Third Avenue
2nd Floor
Miami FL33129
USA |
| Tel. |
+1 305 858 4772 |
| Fax |
+1 305 858 9960 |
|